CD274 and glioblastoma: Exosomal PD-L1 acts as a decoy for PD-1, impairing cytotoxic T lymphocytes; PD-L1^+ vesicles are enriched in glioblastoma, HCC, and GI cancers, correlating with checkpoint resistance [137,138].